Body size and composition and risk of postmenopausal breast cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 13, Issue 12, 2004, Pages 2117-2125

  MacInnis, Robert J ^a   English, Dallas R ^a   Gertig, Dorota M ^a   Hopper, John L ^a   Giles, Graham G ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b CANCER EPIDEMIOLOGY CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; AUSTRALIA; BODY COMPOSITION; BODY FAT; BODY SIZE; BREAST CANCER; CANCER GRADING; CANCER REGISTRY; CANCER RISK; CANCER STAGING; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; IMPEDANCE; INTERVIEW; MAJOR CLINICAL STUDY; OBESITY; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; WAIST CIRCUMFERENCE;

ADIPOSE TISSUE; ADULT; AGED; BODY COMPOSITION; BODY MASS INDEX; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 11144234341     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Vainio H, Bianchini F, Eds. IARC Handbooks of Cancer Prevention. Vol. 6. Weight control and physical activity. Lyon: IARC Press; 2002.
2. Harvie M, Hooper L, Howel AH. Central obesity and breast cancer risk: a systematic review. Obes Rev 2003;4:157-73.
3. Friedenreich CM. Review of anthropometric factors and breast cancer risk. Eur J Cancer Prev 2001;10:15-32.
4. Simpson ER. Sources of estrogen and their importance. J Steroid Biochem Mol Biol 2003;86:225-30.
5. Giles GG. The Melbourne study of diet and cancer. Proc Nutr Soc Aust 1990;15:61-8.
6. Lohman TG, Roche AF, Martorell R. Anthropometric Standardization Reference Manual. Champaign (IL): Kinetics Books; 1988.
7. Giles GG, English DR. The Melbourne Collaborative Cohort Study. IARC Sci Publ 2002;156:69-70.
8. International Union Against Cancer. TNM Classification of Malignant Tumours. 6th ed. Geneva: UICC; 2002.
9. Korn EL, Graubard BI, Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol 1997;145:72-80.
10. Roubenoff R, Baumgartner RN, Harris TB, et al. Application of bioelectrical impedance analysis to elderly populations. J Gerontol A Biol Sci Med Sci 1997;52:M129-36.
11. MacInnis RJ, English DR, Hopper JL, Haydon AM, Gertig DM, Giles GG. Body size and composition and colon cancer risk in men. Cancer Epidemiol Biomarkers Prev 2004;13:553-9.
12. Lunn M, McNeil D. Applying Cox regression to competing risks. Biometrics 1995;51:524-32.
13. Collett D. Modelling survival data in medical research. Boca Raton (FL): Chapman & Hall/CRC; 1999.
14. Reeves MJ, Newcomb PA, Remington PL, Marcus PM, MacKenzie WR. Body mass and breast cancer. Relationship between method of detection and stage of disease. Cancer 1996;77:301-7.
15. MacInnis RJ, English DR, Gertig DM, Hopper JL, Giles GG. Body size and composition and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2003;12:1417-21.
16. Stoll BA. Adiposity as a risk determinant for postmenopausal breast cancer. Int J Obes Relat Metab Disord 2000;24:527-33.
17. Pike MC, Spicer DV, Dahmoush L, Press MF. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 1993;15:17-35.
18. Kim DJ. Report from a symposium on diet and breast cancer. Cancer Causes Control 2002;13:591-4.
19. Cold S, Hansen S, Overvad K, Rose C. A woman's build and the risk of breast cancer. Eur J Cancer 1998;34:1163-74.
20. Juul A, Bang P, Hertel NT, et al. Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab 1994;78:744-52.
21. Nobels F, Dewailly D. Puberty and polycystic ovarian syndrome: the insulin/insulin-like growth factor I hypothesis. Fertil Steril 1992;58:655-66.
22. Rankinen T, Kim SY, Perusse L, Despres JP, Bouchard C. The prediction of abdominal visceral fat level from body composition and anthropometry: ROC analysis. Int J Obes Relat Metab Disord 1999;23:801-9.
23. Janssen I, Heymsfield SB, Allison DB, Kotler DP, Ross R. Body mass index and waist circumference independently contribute to the prediction of nonabdominal, abdominal subcutaneous, and visceral fat. Am J Clin Nutr 2002;75:683-8.
24. Bjorntorp P. Body fat distribution, insulin resistance, and metabolic diseases. Nutrition 1997;13:795-803.
25. Kelley DE, Thaete FL, Troost F, Huwe T, Goodpaster BH. Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am J Physiol Endocrinol Metab 2000;278: E941-8.
26. Stoll BA. Western nutrition and the insulin resistance syndrome: a link to breast cancer. Eur J Clin Nutr 1999;53:83-7.
27. Kaaks R, Stoll BA. Nutrition, hormones, and breast cancer: is insulin the missing link? Western nutrition and the insulin resistance syndrome: a link to breast cancer. Cancer Causes Control 1996; 7:605-25.
28. DeNino WF, Tchernof A, Dionne IJ, et al. Contribution of abdominal adiposity to age-related differences in insulin sensitivity and plasma lipids in healthy nonobese women. Diabetes Care 2001;24:925-32.
29. Potischman N, Swanson CA, Siiteri P, Hoover RN. Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J Natl Cancer Inst 1996;88:756-8.
30. Stoll BA. Teenage obesity in relation to breast cancer risk. Int J Obes Relat Metab Disord 1998;22:1035-40.
31. Siiteri PK. Adipose tissue as a source of hormones. Am J Clin Nutr 1987;45:277-82.
32. van den Brandt PA, Spiegelman D, Yaun SS, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 2000;152:514-27.
33. Yong LC, Brown CC, Schatzkin A, Schairer C. Prospective study of relative weight and risk of breast cancer: the Breast Cancer Detection Demonstration Project follow-up study, 1979 to 1987-1989. Am J Epidemiol 1996;143:985-95.
34. Galanis DJ, Kolonel LN, Lee J, Le Marchand L. Anthropometric predictors of breast cancer incidence and survival in a multi-ethnic cohort of female residents of Hawaii, United States. Cancer Causes Control 1998;9:217-24.
35. Huang Z, Hankinson SE, Colditz GA, et al. Dual effects of weight and weight gain on breast cancer risk. JAMA 1997;278:1407-11.
36. Kaaks R, Van Noord PA, Den Tonkelaar I, Peelers PJ, Riboli E, Grobbee DE. Breast-cancer incidence in relation to height, weight and body-fat distribution in the Dutch "DOM" cohort. Int J Cancer 1998;76:647-51.
37. Morimoto LM, White E, Chen Z, et al. Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States). Cancer Causes Control 2002;13:741-51.
38. Lahmann PH, Lissner L, Gullberg B, Olsson H, Berglund GA. prospective study of adiposity and postmenopausal breast cancer risk: the Malmo Diet and Cancer Study. Int J Cancer 2003;103: 246-52.
39. Huang Z, Willett WC, Colditz GA, et al. Waist circumference, waist:hip ratio, and risk of breast cancer in the Nurses' Health Study. Am J Epidemiol 1999;150:1316-24.
40. Kreiger N, King WD, Rosenberg L, Clarke EA, Palmer JR, Shapiro S. Steroid receptor status and the epidemiology of breast cancer. Ann Epidemiol 1991;1:513-23.
41. Potter JD, Cerhan JR, Sellers TA, et al. Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: how many kinds of breast cancer are there? Cancer Epidemiol Biomarkers Prev 1995;4:319-26.
42. Huang WY, Newman B, Millikan RC, Schell MJ, Hulka BS, Moorman PG. Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol 2000;151:703-14.
43. Enger SM, Ross RK, Paganini-Hill A, Carpenter CL, Bernstein L. Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies. Cancer Epidemiol Biomarkers Prev 2000;9:681-7.
44. Yoo K, Tajima K, Park S, et al. Postmenopausal obesity as a breast cancer risk factor according to estrogen and progesterone receptor status (Japan). Cancer Lett 2001;167:57-63.
45. Sellers TA, Davis J, Cerhan JR, et al. Interaction of waist/hip ratio and family history on the risk of hormone receptor-defined breast cancer in a prospective study of postmenopausal women. Am J Epidemiol 2002;155:225-33.
46. Schapira DV, Kumar NB, Lyman GH, Cox CE. Obesity and body fat distribution and breast cancer prognosis. Cancer 1991;67:523-8.
47. Colditz GA, Rosner BA, Chen WY, Holmes MD, Hankinson SE. Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst 2004;96:218-28.